Henk-Andre Kroon

Henk-Andre Kroon has a strong background in the pharmaceutical and biotech industries, with over two decades of experience. Henk-Andre currently works as the Head of Translational Medicine at Annexon Biosciences, a position they have held since 2019. Prior to this, they worked as an Independent Consultant at Novone Clinical Consulting from 2017 to 2019.

From 2014 to 2017, Henk-Andre served as the Executive VP and Chief Medical Officer at Hallux Inc., a clinical-stage pharmaceutical company focused on targeted subungual drug delivery. Before that, they were the Head of Global Clinical Development at Santen from 2012 to 2014.

Henk-Andre also held the position of VP Clinical Research at Celtic Pharma from 2008 to 2012 and Senior Medical Director at Alexion Pharmaceuticals from 2005 to 2008. Henk-Andre served as the Chief Medical Officer at Protein Sciences Corporation in 2004.

Prior to these roles, Henk-Andre worked at PPD Development as a Strategic Business Development Manager from 1997 to 2004, showcasing their expertise in business development.

Overall, Henk-Andre Kroon has gained valuable experience in various leadership and medical roles, with a focus on clinical development and translational medicine.

Henk-Andre Kroon completed their primary and secondary education at Bogerman School Houten and Dr FH de Bruijnelyceum, respectively. In 1989, they graduated from Utrecht University with a degree in Medicine (MD). Later, from 1995 to 1997, they pursued an MBA degree at the University of Cape Town.